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Background
•
•

Regulation of the Wnt/β-catenin Pathway. When the
pathway is inactive (left), GSK3β regulates β-catenin content in
the cytoplasm through phosphorylation. During activation
(right), however, GSK3β is inhibited, allowing β-catenin to
proliferate in the cytoplasm and translocate to the nucleus,
where it then regulates gene expression. Figure from Anastas,
J.N.; Moon, R.T. 2013. WNT signalling pathways as
therapeutic targets in cancer. Nature Reviews Cancer 13: 1126.

Estrogens and progestins regulate the menstrual
cycle, including regulation of the Wnt/β-catenin
pathway.1
The pathway regulates genes involved in cell
proliferation and apoptosis. It is implicated in ovarian
cancer and it is used as a marker for Epithelial
Ovarian Cancer (EOC)2, where high levels of βcatenin may be involved in tumor development3

Bisphenol A (BPA)

Objective
•

Monitor the Wnt/β-catenin pathway’s activity following
exposure to different steroid hormones by using βcatenin (ctnnb1) and GSK3β as markers, as well as
p53 and c-MYC, target genes for this pathway

Methods
• Collect ovary tissue from zebrafish (Danio rerio) and
incubate in 60% L-15 medium (with 1x
antibiotic/antimycotic) and given steroid hormone (0, 1,
10, 100 ng/mL) at 26 °C for 4 hours
• Extract mRNA and convert to cDNA (50 ng/μL)
• Perform real time quantitative (rt-q)PCR to quantify
relative concentrations of mRNA present in the ovary
tissue

17β-Estradiol (Estrogen)

5α-dihydrotestosterone (DHT)

Discussion
•
•

•

DHT appears to inhibit the pathway, although p53 and
c-MYC expression increase with DHT concentration
Estrogen affects the pathway in a dose-dependent
manner, with 10 ng/mL producing the largest
response. The vehicle control (MeOH) also appears
to have a significant impact. Expression of c-MYC
decreases with an increasing concentration of
estrogen, while the expression of p53 only mildly
increases
BPA exposure appears to stimulate the pathway,
notably at 1 ng/mL, while p53 and c-MYC expression
seem to be dose dependent
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